Chemistry and Physics of Lipids, 64 (1993) 287-289 Elsevier Scientific Publishers Ireland Ltd. Subject Index Volume 64 (1993) anaesthetics, history, structure properties, surrogacy, lung- fatty acid oxidation, lipid peroxidation, cholesterol oxidation, surfactants, 275 phospholipid oxidation, unilamellar, multilamellar lipo- analysis, lipid peroxidation, cholesterol oxidation, fatty acid somes, small unilamellar vesicles (SUV), multilamellar oxidation, phospholipid oxidation, unilamellar, multilam- vesicles (MLV), analysis, 19 ellar liposomes, small unilamellar vesicles (SUV), multi- Fe, diagnostic X-ray spectroscopy (DXS), liposomes, Ca, Cu, lamellar vesicles (MLV), 19 Zn, trace elements analysis, liposome quality control, 31 fluorescent anisotropy, fluorescent polarization, fluorescent blood circulation, liposome, glycolipid, polyethylene glycol probes, multiprobe, liposome, lipid assembly, 117 (PEG), tissue distribution, plasma interaction, surface fluorescent polarization, fluorescent anisotropy, fluorescent potential, 249 probes, multiprobe, liposome, lipid assembly, 117 Brownian motion, light scattering, photon correlation, fluorescent probes, diphenylhexatriene, parinaric acid, lipo- polydispersity analysis, 45 some, structure/dynamics, review, 99 fluorescent probes, fluorescent polarization, fluorescent aniso- Ca, diagnostic X-ray spectroscopy (DXS), liposomes, Fe, Cu, tropy, multiprobe, liposome, lipid assembly, 117 Zn, trace elements analysis, liposome quality control, 31 formation, vesicles, stability, size distribution, thermeJy- captured volume, liposomes, lamellarity, interdigitation-fusion namics, 35 vesicles, drug delivery, 197 fusion, gel exclusion chromatography, HPLC, liposome, vesicle characterization, differential scanning calorimetry, liposomes, aggregation, polydispersity, size, distribution, 57 quality control, stability, phospholipids, 128 charge effects, surface potential, membranes, ion binding, lipid gel exclusion chromatography, HPLC, liposome, vesicle aggre- bilayers, 163 gation, fusion, polydispersity, size, distribution, 57 cholesterol oxidation, lipid peroxidation, fatty acid oxidation, glycolipid, liposome, polyethylene glycol (PEG), blood circula- phospholipid oxidation, unilamellar, multilamellar lipo- tion, tissue distribution, plasma interaction, surface poten- somes, small unilamellar vesicles (SUV), multilamellar tial, 249 vesicles (MLV), analysis, 19 complement, liposomes, phagocytosis, opsonization, stealth haemolysis, liposomes, toxicity tests, thrombosis, cytotoxicity, lipids, negative charge, 239 phagocytosis, pyrogenicity, 263 Cu, diagnostic X-ray spectroscopy (DXS), liposomes, Ca, Fe, history, structure properties, surrogacy, anaesthetics, lung- Zn, trace elements analysis, liposome quality control, 31 surfactants, 275 cytotoxicity, liposomes, toxicity tests, haemolysis, thrombosis, HPLC analysis of phospholipids, liposomes, phospholipids, phagocytosis, pyrogenicity, 263 oxidation, hydrolysis, physical stability, quality control, 3 HPLC, gel exclusion chromatography, liposome, vesicle aggre- diagnostic X-ray spectroscopy (DXS), liposomes, Ca, Fe, Cu, gation, fusion, polydispersity, size, distribution, 57 Zn, trace elements analysis, liposome quality control, 31 hydrolysis, liposomes, phospholipids, oxidation, physical differential scanning calorimetry, liposomes, quality control, stability, quality control, HPLC analysis of phospholipids, stability, characterization, phospholipids, 128 3 dilution release assay, liposomes, sterically stabilized lipo- somes, doxorubicin delivery, liposome pharmacokinetics, interdigitation-fusion vesicles, liposomes, captured volume, liposome quality control, 219 lamellarity, drug delivery, 197 diphenylhexatriene, parinaric acid, liposome, structure/dyna- ion binding, surface potential, membranes, charge effects, lipid mics, fluorescent probes, review, 99 bilayers, 163 distribution, gel exclusion chromatography, HPLC, liposome, vesicle aggregation, fusion, polydispersity, size, 57 lamellarity, liposomes, captured volume, interdigitation-fusion doxorubicin delivery, liposomes, sterically stabilized liposomes, vesicles, drug delivery, 197 dilution release assay, liposome pharmacokinetics, lipo- light scattering, photon correlation, Brownian motion, some quality control, 219 polydispersity analysis, 45 drug delivery, liposomes, captured volume, lamellarity, lipid assembly, fluorescent polarization, fluorescent aniso- interdigitation-fusion vesicles, 197 tropy, fluorescent probes, multiprobe, liposome, 117 288 lipid bilayers, surface potential, membranes, ion binding, multilamellar vesicles (MLV), lipid peroxidation, cholesterol charge effects, 163 oxidation, fatty acid oxidation, phospholipid oxidation, lipid peroxidation, cholesterol oxidation, fatty acid oxidation, unilamellar, multilamellar liposomes, small unilamellar phospholipid oxidation, unilamellar, multilamellar lipo- vesicles (SUV), analysis, 19 somes, small unilamellar vesicles (SUV), multilamellar multiprobe, fluorescent polarization, fluorescent anisotropy, vesicles (MLV), analysis, 19 fluorescent probes, liposome, lipid assembly, 117 lipidic ionophores, liposomes, osmotic volume change, perme- ability, permeant-solvent interaction, 187 negative charge, liposomes, complement, phagocytosis, opson- liposome pharmacokinetics, liposomes, sterically stabilized ization, stealth lipids, 239 liposomes, doxorubicin delivery, dilution release assay, NMR, vesicles, liposomes, 143 liposome quality control, 219 liposome quality control, diagnostic X-ray spectroscopy (DXS), liposomes, Ca, Fe, Cu, Zn, trace elements analysis, opsonization, liposomes, complement, phagocytosis, stealth 31 lipids, negative charge, 239 liposome quality control, liposomes, sterically stabilized lipo- osmotic volume change, liposomes, permeability, permeant- somes, doxorubicin delivery, dilution release assay, lipo- solvent interaction, lipidic ionophores, 187 some pharmacokinetics, 219 oxidation, liposomes, phospholipids, hydrolysis, physical liposome, diphenylhexatriene, parinaric acid, structure/dyna- stability, quality control, HPLC analysis of phospholipids, 3 mics, fluorescent probes, review, 99 liposome, fluorescent polarization, fluorescent anisotropy, fluorescent probes, multiprobe, lipid assembly, 117 parinaric acid, diphenylhexatriene, liposome, structure/dyna- liposome, gel exclusion chromatography, HPLC, vesicle aggre- mics, fluorescent probes, review, 99 gation, fusion, polydispersity, size, distribution, 57 permeant-solvent interaction, liposomes, osmotic volume liposome, glycolipid, polyethylene glycol (PEG), blood circula- change, permeability, lipidic ionophores, 187 tion, tissue distribution, plasma interaction, surface poten- permeability, liposomes, osmotic volume change, permeant- tial, 249 solvent interaction, lipidic ionophores, 187 liposomes, captured volume, lamellarity, interdigitation-fusion phagocytosis, liposomes, complement, opsonization, stealth vesicles, drug delivery, 197 lipids, negative charge, 239 liposomes, complement, phagocytosis, opsonization, stealth phagocytosis, liposomes, toxicity tests, haemolysis, thrombosis, lipids, negative charge, 239 cytotoxicity, pyrogenicity, 263 liposomes, diagnostic X-ray spectroscopy (DXS), Ca, Fe, Cu, phospholipid oxidation, lipid peroxidation, cholesterol oxida- Zn, trace elements analysis, liposome quality control, 31 tion, fatty acid oxidation, unilamellar, multilamellar lipo- liposomes, differential scanning calorimetry, quality control, somes, small unilamellar vesicles (SUV), multilamellar stability, characterization, phospholipids, 128 vesicles (MLV), analysis, 19 liposomes, NMR, vesicles, 143 phospholipids, differential scanning calorimetry, liposomes, liposomes, osmotic volume change, permeability, permeant- quality control, stability, characterization, 128 solvent interaction, lipidic ionophores, 187 phospholipids, liposomes, oxidation, hydrolysis, physical liposomes, phospholipids, oxidation, hydrolysis, physical stability, quality control, HPLC analysis of phospholipids, stability, quality control, HPLC analysis of phospholipids, 3 3 photon correlation, light scattering, Brownian motion, liposomes, sterically stabilized liposomes, doxorubicin delivery, polydispersity analysis, 45 dilution release assay, liposome pharmacokinetics, lipo- physical stability, liposomes, phospholipids, oxidation, some quality control, 219 hydrolysis, quality control, HPLC analysis of phospho- liposomes, toxicity tests, haemolysis, thrombosis, cytotoxicity, lipids, 3 phagocytosis, pyrogenicity, 263 plasma interaction, liposome, glycolipid, polyethylene glycol liposomes, vesicles, membranes, small angle X-ray diffraction, (PEG), blood circulation, tissue distribution, surface poten- 83 tial, 249 lung-surfactants, history, structure properties, surrogacy, polyethylene glycol (PEG), liposome, glycolipid, blood circula- anaesthetics, 275 tion, tissue distribution, plasma interaction, surface poten- tial, 249 membranes, surface potential, ion binding, charge effects, lipid polydispersity analysis, light scattering, photon correlation, bilayers, 163 brownian motion, 45 membranes, liposomes, vesicles, small angle X-ray diffraction, polydispersity, gel exclusion chromatography, HPLC, lipo- 83 some, vesicle aggregation, fusion, size, distribution, 57 multilamellar liposomes, lipid peroxidation, cholesterol oxida- preface, | tion, fatty acid oxidation, phospholipid oxidation, pyrogenicity, liposomes, toxicity tests, haemolysis, thrombosis, unilamellar, small unilamellar vesicles (SUV), multilamellar cytotoxicity, phagocytosis, 263 vesicles (MLV), analysis, 19 289 quality control, differential scanning calorimetry, liposomes, (PEG), blood circulation, tissue distribution, plasma inter- stability, characterization, phospholipids, 128 action, 249 quality control, liposomes, phospholipids, oxidation, hydroly- surface potential, membranes, ion binding, charge effects, lipid sis, physical stability, HPLC analysis of phospholipids, 3 bilayers, 163 surrogacy, history, structure properties, anaesthetics, lung- surfactants, 275 review, diphenylhexatriene, parinaric acid, liposome, struc- ture/dynamics, fluorescent probes, 99 thermodynamics, vesicles, stability, formation, size distribu- tion, 35 thrombosis, liposomes, toxicity tests, haemolysis, cytotoxicity, size distribution, vesicles, stability, formation, thermody- phagocytosis, pyrogenicity, 263 namics, 35 tissue distribution, liposome, glycolipid, polyethylene glycol size, gel exclusion chromatography, HPLC, liposome, vesicle (PEG), blood circulation, plasma interaction, surface aggregation, fusion, polydispersity, distribution, 57 potential, 249 small angle X-ray diffraction, liposomes, vesicles, membranes, toxicity tests, liposomes, haemolysis, thrombosis, cytotoxicity, 83 phagocytosis, pyrogenicity, 263 small unilamellar vesicles (SUV), lipid peroxidation, choles- trace elements analysis, diagnostic X-ray spectroscopy (DXS), terol oxidation, fatty acid oxidation, phospholipid oxida- liposomes, Ca, Fe, Cu, Zn, liposome quality control, 31 tion, unilamellar, multilamellar liposomes, multilamellar vesicles (MLV), analysis, 19 unilamellar, lipid peroxidation, cholesterol oxidation, fatty stability, differential scanning calorimetry, liposomes, quality acid oxidation, phospholipid oxidation, multilamellar lipo- control, characterization, phospholipids, 128 somes, small unilamellar vesicles (SUV), multilamellar vesi- stability, vesicles, formation, size distribution, thermody- cles (MLV), analysis, 19 namics, 35 vesicle aggregation, gel exclusion chromatography, HPLC, stealth lipids, liposomes, complement, phagocytosis, opsoniza- liposome, fusion, polydispersity, size, distribution, 57 tion, negative charge, 239 sterically stabilized liposomes, liposomes, doxorubicin delivery, vesicles, liposomes, membranes, small angle X-ray diffraction, dilution release assay, liposome pharmacokinetics, lipo- 83 some quality control, 219 vesicles, NMR, liposomes, 143 structure properties, history, surrogacy, anaesthetics, lung- vesicles, stability, formation, size distribution, thermodynam- surfactants, 275 ics, 35 structure/dynamics, diphenylhexatriene, parinaric acid, lipo- some, fluorescent probes, review, 99 Zn, diagnostic X-ray spectroscopy (DXS), liposomes, Ca, Fe, surface potential, liposome, glycolipid, polyethylene glycol Cu, trace elements analysis, liposome quality control, 31 Chemistry and Physics of Lipids, 64 (1993) 291 Elsevier Scientific Publishers Ireland Ltd. Author Index Volume 63 (1993) Ahl, P.L. 197 Lang, J.K. Alving, C.R. 239 Lasic, D.D. Amselem, S. 31, 219 Lentz, B.R. Lesieur, S. Bangham, A.D. 275 Lichtenberg, D. Barenholz, Y. 1, 31, 117, 219 Biltonen, R.L. Minchey, S.R. Borenstain, V. Bouwstra, J.A. Ollivon, M. Bras, W. Ostrowsky, N. Ceve, G. Parnham, M.J. Cohen, R. Paternostre, M. Crommelin, D.J.A. Perkins, W.R. Fenske, D.B. Talsma, H. de Gier, J. Vigo-Pelfrey, C. Gooris, G.S. Gorodetsky, R. Wassef, N.M. Grabielle-Medelmont, C. Wetzig, H. Grit, M. Winterhalter, M. Woodle, M.C. Janoff, A.S.